Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy

Jean‐Marc Kaufman(Ghent University Hospital), B. Mitlak(Eli Lilly (United States)), G. P. Dalsky(Eli Lilly (United States)), Robert S. Lindsay(National Institutes of Health), Javier San Martín(Amgen (United States)), Eric Orwoll(Oregon Health & Science University), Stefan Goemaere(Ghent University Hospital), Anwar Hossain(Eli Lilly (United States))
Osteoporosis International
August 17, 2004
Cited by 320


Related Papers